Avacta Group
AVCT · AIM · Health Care · mcap £329m · 65.5p
Financials · LTM to 30 Jun 26
Source: results 30 Sep 26 ↗
- Revenue
- £113k
- Operating profit
- −£29.6m
- Net income
- −£39.9m
- Free cash flow
- −£28.6m
- Net cash
- £4.5m
- Market cap
- £321m
- EV / EBIT
- –
- FCF yield
- −8.9%
- Price / book
- 85.1×
Latest half-year · H1 26 vs H1 25
results 30 Sep 26 ↗
- Revenue
- £56k +0%
- Operating profit
- −£13.9m prior −£14.2m
- Net income
- −£19.0m prior −£17.7m
- Cash from operations
- −£14.3m prior −£13.6m
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: H1 26 (six months to 30 Jun 26), published 30 Sep 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Revenue | 0.1 | 0.1 | 0.1 |
| Gross profit | 0.1 | 0.1 | 0.1 |
| Adjusted EBITDA | (26.2) | (25.3) | – |
| Exceptional / adjusting items | 0.2 | (0.8) | 2.0 |
| Operating profit | (29.6) | (29.9) | (32.6) |
| Depreciation (owned assets) | – | (1.3) | (1.5) |
| Amortisation | (0.0) | (0.0) | (0.0) |
| Share-based payments | (1.9) | (2.1) | (4.1) |
| Finance costs | (0.0) | (0.1) | – |
| Profit before tax | (38.0) | (36.0) | (29.0) |
| Tax | (1.1) | (0.2) | (0.4) |
| Net income (owners) | (39.9) | (38.6) | (52.8) |
| Discontinued operations | – | (2.1) | (23.4) |
| EPS basic | (9.2p) | (9.7p) | (15.3p) |
| EPS diluted | (9.2p) | (9.7p) | (15.3p) |
| H1 26 | vs H1 25 | H2 25 | H1 25 | |
|---|---|---|---|---|
| Revenue | 0.1 | n/m | 0.1 | 0.1 |
| Gross profit | 0.1 | n/m | 0.1 | 0.1 |
| Adjusted EBITDA | (12.6) | n/m | (13.7) | (11.6) |
| Exceptional / adjusting items | 0.0 | n/m | 0.1 | (0.9) |
| Operating profit | (13.9) | n/m | (15.7) | (14.2) |
| Amortisation | (0.0) | n/m | (0.0) | (0.0) |
| Share-based payments | (0.5) | −28% | (1.4) | (0.7) |
| Finance costs | (0.0) | n/m | (0.0) | (0.1) |
| Profit before tax | (18.8) | n/m | (19.2) | (16.9) |
| Tax | (0.2) | n/m | (1.0) | 0.7 |
| Net income (owners) | (19.0) | n/m | (20.9) | (17.7) |
| Discontinued operations | – | – | (1.2) | (0.9) |
| EPS basic | (4.2p) | – | (5.0p) | (4.7p) |
| EPS diluted | (4.2p) | – | (5.0p) | (4.7p) |
| Latest Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Other intangibles | 1.6 | 1.5 | 1.8 |
| Property, plant & equipment | 0.2 | 0.3 | 0.5 |
| Associates & JVs | 2.9 | 3.1 | 3.4 |
| Trade receivables | 5.4 | 4.5 | 2.0 |
| Cash | 20.3 | 16.9 | 12.9 |
| Current assets | 25.7 | 23.2 | 40.2 |
| Total assets | 30.9 | 29.4 | 48.3 |
| Trade payables | 7.3 | 8.9 | 5.9 |
| Borrowings, current | 15.8 | 13.4 | 20.5 |
| Lease liabilities, current | 0.8 | 1.1 | 1.0 |
| Current liabilities | 27.1 | 26.2 | 37.3 |
| Lease liabilities, non-current | 0.0 | 0.5 | 1.5 |
| Total liabilities | 27.2 | 26.9 | 39.0 |
| Total equity | 3.8 | 2.5 | 9.3 |
| H1 26 | H2 25 | H1 25 | H2 24 | |
|---|---|---|---|---|
| Other intangibles | 1.6 | 1.5 | 1.8 | 1.8 |
| Property, plant & equipment | 0.2 | 0.3 | 0.3 | 0.5 |
| Associates & JVs | 2.9 | 3.1 | 3.3 | 3.4 |
| Trade receivables | 5.4 | 4.5 | 3.0 | 2.0 |
| Cash | 20.3 | 16.9 | 12.6 | 12.9 |
| Current assets | 25.7 | 23.2 | 22.0 | 40.2 |
| Total assets | 30.9 | 29.4 | 29.2 | 48.3 |
| Trade payables | 7.3 | 8.9 | 6.6 | 5.9 |
| Borrowings, current | 15.8 | 13.4 | 18.2 | 20.5 |
| Lease liabilities, current | 0.8 | 1.1 | 1.0 | 1.0 |
| Current liabilities | 27.1 | 26.2 | 27.9 | 37.3 |
| Lease liabilities, non-current | 0.0 | 0.5 | 1.0 | 1.5 |
| Total liabilities | 27.2 | 26.9 | 29.1 | 39.0 |
| Total equity | 3.8 | 2.5 | 0.1 | 9.3 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.